GLP-1 medications act as a GLP-1 hormone (made in your small intestine) to help slow down the movement of food through your stomach while increasing the feeling of fullness so you eat less
These events are well recognised with incretin-based therapies such as GLP-1 receptor agonists, and retatrutide has shown a similar pattern in the early studies
Michaela Diamant from the University of Amsterdam, The Netherlands, talked about the importance of the incretin GLP-1 as a determinant of the attenuated insulin response to a meal seen in patients with type 2 diabetes
"Expanding coverage and affordability of treatments is vital to people living with obesity
However, the quality and frequency of these follow-ups varies based on customer reports
Reduce if you have experienced a medical event, surgery, or illness that has compromised your baseline state